Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection gains USFDA fast track…
Sanofi is planning a phase 1/2 randomised, clinical study designed to evaluate the immunogenicity and safety of the chlamydia…
Recover your password.
A password will be e-mailed to you.